COMPANY PROFILE

PCCI

Explore full profile

And implements highly accurate predictive models to help deliver patient care in a timely

Dallas, United StatesFounded 2012Health Tech & Medtech

Valuation $100–250M Last recorded · 2016

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About PCCI

PCCIPieces.org is a specialized platform that provides in-depth reviews and insights on online casinos, catering to both novice and experienced players. Operating in the online gambling market, the platform evaluates various casinos based on their gameplay, bonuses, and transaction reliability. One of its unique selling points is the emphasis on blockchain technology to ensure transparent and secure transactions, which adds a layer of trust for users. The business model revolves around generating revenue through affiliate marketing, where the platform earns commissions from casinos when users sign up or make deposits through their links. Additionally, PCCIPieces.org offers regular updates on new games, promotions, and exclusive bonuses, making it a go-to resource for online casino enthusiasts. The platform serves a global audience, with a particular focus on markets where online gambling is popular and regulated.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2012
Headquarters: Dallas, United States
Employees: 390
Open positions: None listed
Dealroom signal: 50.4/100
Industry: Health
Sub-industry: Health Platform
Sector: Health Tech & Medtech, Risk Management, Predictive Analytics, Research and Development, Cardiology and cardiovascular, Patient Care, Spinout, DT and LS, science-based
Technology: Big Data, Deep Tech
Client focus: b2b
Investment activity: 1 company, latest Mar 2016
Capital deployed: $22M
Preferred round: SERIES A
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Feb 2016	$19M	$74M	Undisclosed	—
SPINOUT✓Other financing	Jan 2012	$0	—	The University of Texas Southwestern Medical School	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

PCCI website traffic

Latest recorded traffic for PCCI is 0 monthly website visits. PCCI's team grew 6.3% over the past year.

Latest monthly visits0 1-year team growth+6.3%

Monthly website visitsOct 2017–May 2020

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HSHealth Outcomes SciencesHOS personalizes predictive analytics and evidence at the point of care, helping physicians reduce variance and improve outcomes	Overland Park, United States	Acquired	10	$18M	$7.6M
OMOncora MedicalHelps doctors use data to make better decisions for cancer patients	Philadelphia, United States	Operational
PTPear TherapeuticsPear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need	Boston, United States	Operational
CRCroivalveTreating Heart Valve Disease	Dublin, Ireland	Operational
COCorindusCorindus develops and commercializes remote robotic systems for interventional procedures	Natick, United States	Acquired
SYSymetisMinimally invasive heart valve replacement therapies for patients suffering from heart valve diseases	Ecublens, Switzerland	Acquired
SISingulexLife Science Products and Cardiovascular Monitoring	Alameda, United States	Operational
OPOptimataOptimata uses high-level, multiscale modeling that integrates rational analysis of treatment mechanisms with information from large databases to develop solutions for predicting an oncology patient’s prognosis and the benefit they may gain from drug	Bnei Atarot, Israel	Operational